Defining pluripotent stem cells through quantitative proteomic analysis

Expert Review of Proteomics

Volumn 8, Issue 1, 2011, Pages 29-42

  Reiland, Sonja ^a   Salekdeh, Ghasem Hosseini ^b   Krijgsveld, Jeroen ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

Author keywords

cell surface marker; chromatin dynamics; differentiation; embryonic stem cell; induced pluripotent stem cell; mass spectrometry; phosphoproteome; post translational modifications; protein quantification; proteomics; regenerative medicine

Indexed keywords

CELL PROTEIN; HISTONE; LEUKEMIA INHIBITORY FACTOR; PHOSPHOPROTEOME; PROTEOME; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL EXPANSION; CELL MEMBRANE; CELL RENEWAL; CHROMATIN STRUCTURE; EMBRYONIC STEM CELL; GEL ELECTROPHORESIS; HUMAN; MEDICAL ETHICS; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL;

ANIMALS; CELL DIFFERENTIATION; CHROMATIN; CHROMATOGRAPHY, LIQUID; EMBRYONIC STEM CELLS; EVALUATION STUDIES AS TOPIC; HISTONES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MASS SPECTROMETRY; MICE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; RECEPTORS, CELL SURFACE; REGENERATIVE MEDICINE;

EID: 79951893034     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.10.100     Document Type: Review

References (155)

1. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse (Pubitemid 11050741)
2. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78(12), 7634-7638 (1981). (Pubitemid 12186197)
3. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 282(5391), 1145-1147 (1998). (Pubitemid 28516247)
4. Yu J, Thomson JA. Pluripotent stem cell lines. Genes Dev. 22(15), 1987-1997 (2008).
5. Pera MF, Tam PP. Extrinsic regulation of pluripotent stem cells. Nature 465(7299), 713-720 (2010).
6. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132(4), 567-582 (2008). (Pubitemid 351253686)
7. Zhang X, Stojkovic P, Przyborski S et al. Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells 24(12), 2669-2676 (2006). (Pubitemid 46070118)
8. Kim K, Lerou P, Yabuuchi A et al. Histocompatible embryonic stem cells by parthenogenesis. Science 315(5811), 482-486 (2007). (Pubitemid 46178390)
9. Chung Y, Klimanskaya I, Becker S et al. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 439(7073), 216-219 (2006). (Pubitemid 43083144)
10. Brons IG, Smithers LE, Trotter MW et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448(7150), 191-195 (2007). (Pubitemid 47067373)
11. Tesar PJ, Chenoweth JG, Brook FA et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448(7150), 196-199 (2007). (Pubitemid 47067378)
12. Byrne JA, Pedersen DA, Clepper LL et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 450(7169), 497-502 (2007). (Pubitemid 350190255)
13. Simerly C, Dominko T, Navara C et al. Molecular correlates of primate nuclear transfer failures. Science 300(5617), 297 (2003). (Pubitemid 36433715)
14. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006). (Pubitemid 44233629)
15. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25(10), 1177-1181 (2007). (Pubitemid 47538112)
16. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448(7151), 313-317 (2007). (Pubitemid 47080336)
17. Nakagawa M, Koyanagi M, Tanabe K et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26(1), 101-106 (2008).
18. Maherali N, Sridharan R, Xie W et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1(1), 55-70 (2007).
19. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861-872 (2007). (Pubitemid 350138099)
20. Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175), 141-146 (2008).
21. Lowry WE, Richter L, Yachechko R et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl Acad. Sci. USA 105(8), 2883-2888 (2008). (Pubitemid 351723638)
22. Yu JY, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858), 1917-1920 (2007).
23. Shao L, Feng W, Sun Y et al. Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res. 19(3), 296-306 (2009).
24. Carey BW, Markoulaki S, Hanna J et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc. Natl Acad. Sci. USA 106(1), 157-162 (2009).
25. Sommer CA, Stadtfeld M, Murphy GJ, Hochedlinger K, Kotton DN, Mostoslavsky G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27(3), 543-549 (2009).
26. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458(7239), 771-775 (2009).
27. Soldner F, Hockemeyer D, Beard C et al. Parkinsons disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136(5), 964-977 (2009).
28. Woltjen K, Michael IP, Mohseni P et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458(7239), 766-770 (2009).
29. Yusa K, Rad R, Takeda J, Bradley A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat. Methods 6(5), 363-369 (2009).
30. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 322(5903), 945-949 (2008).
31. Okita K, Nakagawa M, Hong HJ, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322(5903), 949-953 (2008).
32. Gonzalez F, Barragan Monasterio M, Tiscornia G et al. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc. Natl Acad. Sci. USA 106(22), 8918-8922 (2009).
33. Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324(5928), 797-801 (2009).
34. Zhou HY, Wu SL, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4(5), 381-384 (2009).
35. Kim D, Kim CH, Moon JI et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4(6), 472-476 (2009).
36. Zhao X, Li W, Lv Z et al. iPS cells produce viable mice through tetraploid complementation. Nature 461(7260), 86-90 (2009).
37. Maherali N, Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3(6), 595-605 (2008).
38. OMalley J, Woltjen K, Kaji K. New strategies to generate induced pluripotent stem cells. Curr. Opin. Biotechnol. 20(5), 516-521 (2009).
39. Martins-Taylor K, Xu RH. Determinants of pluripotency: from avian, rodents, to primates. J. Cell Biochem. 109(1), 16-25 (2010).
40. Selvaraj V, Plane JM, Williams AJ, Deng WB. Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies. Trends Biotechnol. 28(4), 214-223 (2010).
41. Aoi T, Yae K, Nakagawa M et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321(5889), 699-702 (2008).
42. Miura K, Okada Y, Aoi T et al. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 27(8), 743-745 (2009).
43. Kim K, Doi A, Wen B et al. Epigenetic memory in induced pluripotent stem cells. Nature 467(7313), 285-290 (2010).
44. Polo JM, Liu S, Figueroa ME et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28(8), 848-855 (2010).
45. Chan EM, Ratanasirintrawoot S, Park IH et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 27(11), 1033-1037 (2009).
46. Taura D, Noguchi M, Sone M et al. Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett. 583(6), 1029-1033 (2009).
47. Feng Q, Lu SJ, Klimanskaya I et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28(4), 704-712 (2010).
48. Marchetto MCN, Yeo GW, Kainohana O, Marsala M, Gage FH, Muotri AR. Transcriptional signature and memory retention of human-induced pluripotent stem cells. Plos One 4(9), e7076 (2009).
49. Chin MH, Mason MJ, Xie W et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5(1), 111-123 (2009).
50. Stadtfeld M, Apostolou E, Akutsu H et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465(7295), 175-181 (2010).
51. Guenther MG, Frampton GM, Soldner F et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell. 7(2), 249-257 (2010).
52. Mann M, Kelleher NL. Precision proteomics: the case for high resolution and high mass accuracy. Proc. Natl Acad. Sci. USA 105(47), 18132-18138 (2008).
53. Picotti P, Bodenmiller B, Mueller LN, Domon B, Aebersold R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138(4), 795-806 (2009).
54. de Godoy LM, Olsen JV, Cox J et al. Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 455(7217), 1251-1254 (2008).
55. Motoyama A, Yates JR 3rd. Multidimensional LC separations in shotgun proteomics. Anal. Chem. 80(19), 7187-7193 (2008).
56. Ong SE, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 1(5), 252-262 (2005).
57. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17(10), 994-999 (1999). (Pubitemid 29474856)
58. Oda Y, Huang K, Cross FR, Cowburn D, Chait BT. Accurate quantitation of protein expression and site-specific phosphorylation. Proc. Natl Acad. Sci. USA 96(12), 6591-6596 (1999). (Pubitemid 29274927)
59. Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B. Quantitative mass spectrometry in proteomics: a critical review. Anal. Bioanal. Chem. 389(4), 1017-1031 (2007). (Pubitemid 47482251)
60. Elliott MH, Smith DS, Parker CE, Borchers C. Current trends in quantitative proteomics. J. Mass Spectrom. 44(12), 1637-1660 (2009).
61. Mann M. Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. 7(12), 952-958 (2006). (Pubitemid 44871421)
62. Karp NA, Huber W, Sadowski PG, Charles PD, Hester SV, Lilley KS. Addressing accuracy and precision issues in iTRAQ quantitation. Mol. Cell Proteomics 9(9), 1885-1897 (2010).
63. Unwin RD, Smith DL, Blinco D et al. Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells. Blood 107(12), 4687-4694 (2006). (Pubitemid 43882616)
64. Graumann J, Hubner NC, Kim JB et al. Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins. Mol. Cell Proteomics 7(4), 672-683 (2008). (Pubitemid 351597479)
65. Van Hoof D, Pinkse MW, Oostwaard DW, Mummery CL, Heck AJ, Krijgsveld J. An experimental correction for arginine-to-proline conversion artifacts in SILAC-based quantitative proteomics. Nat. Methods 4(9), 677-678 (2007). (Pubitemid 47338150)
66. Prokhorova TA, Rigbolt KT, Johansen PT et al. Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells. Mol. Cell Proteomics 8(5), 959-970 (2009).
67. Bendall SC, Hughes C, Stewart MH, Doble B, Bhatia M, Lajoie GA. Prevention of amino acid conversion in SILAC experiments with embryonic stem cells. Mol. Cell Proteomics 7(9), 1587-1597 (2008).
68. Choudhary C, Mann M. Decoding signalling networks by mass spectrometry-based proteomics. Nat. Rev. Mol. Cell Biol. 11(6), 427-439 (2010).
69. OBrien RN, Shen Z, Tachikawa K, Lee PJ, Briggs SP. Quantitative proteome analysis of pluripotent cells by iTRAQ mass tagging reveals post-transcriptional regulation of proteins required for ES cell self-renewal. Mol. Cell Proteomics 9(10), 2238-2251 (2010).
70. Williamson AJ, Smith DL, Blinco D et al. Quantitative proteomics analysis demonstrates post-transcriptional regulation of embryonic stem cell differentiation to hematopoiesis. Mol. Cell Proteomics 7(3), 459-472 (2008). (Pubitemid 351472457)
71. Fathi A, Pakzad M, Taei A et al. Comparative proteome and transcriptome analyses of embryonic stem cells during embryoid body-based differentiation. Proteomics 9(21), 4859-4870 (2009).
72. Lu R, Markowetz F, Unwin RD et al. Systems-level dynamic analyses of fate change in murine embryonic stem cells. Nature 462(7271), 358-362 (2009).
73. Sampath P, Pritchard DK, Pabon L et al. A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation. Cell Stem Cell 2(5), 448-460 (2008). (Pubitemid 351598082)
74. Baharvand H, Fathi A, Gourabi H, Mollamohammadi S, Salekdeh GH. Identification of mouse embryonic stem cell-associated proteins. J. Proteome Res. 7(1), 412-423 (2008). (Pubitemid 351171155)
75. Nasrabadi D, Rezaei Larijani M, Pirhaji L et al. Proteomic analysis of monkey embryonic stem cell during differentiation. J. Proteome Res. 8(3), 1527-1539 (2009).
76. Kadota M, Nishigaki R, Wang CC et al. Proteomic signatures and aberrations of mouse embryonic stem cells containing a single human chromosome 21 in neuronal differentiation: an in vitro model of Down syndrome. NeuroScience 129(2), 325-335 (2004). (Pubitemid 39388852)
77. Guo X, Ying W, Wan J et al. Proteomic characterization of early-stage differentiation of mouse embryonic stem cells into neural cells induced by all-trans retinoic acid in vitro. Electrophoresis 22(14), 3067-3075 (2001).
78. Kurisaki A, Hamazaki TS, Okabayashi K et al. Chromatin-related proteins in pluripotent mouse embryonic stem cells are downregulated after removal of leukemia inhibitory factor. Biochem. Biophys. Res. Commun. 335(3), 667-675 (2005). (Pubitemid 41188251)
79. Barthéléry M, Jaishankar A, Salli U, Vrana KE. Reptin52 expression during in vitro neural differentiation of human embryonic stem cells. Neurosci. Lett. 452(1), 47-51 (2009).
80. Nasrabadi D, Larijani MR, Fathi A et al. Nuclear proteome analysis of monkey embryonic stem cells during differentiation. Stem Cell Rev. 6(1), 50-61 (2010).
81. Van Hoof D, Passier R, Ward-Van Oostwaard D et al. A quest for human and mouse embryonic stem cell-specific proteins. Mol. Cell Proteomics 5(7), 1261-1273 (2006). (Pubitemid 44103397)
82. Yocum AK, Gratsch TE, Leff N et al. Coupled global and targeted proteomics of human embryonic stem cells during induced differentiation. Mol. Cell Proteomics 7(4), 750-767 (2008). (Pubitemid 351597485)
83. Chaerkady R, Kerr CL, Marimuthu A et al. Temporal analysis of neural differentiation using quantitative proteomics. J. Proteome Res. 8(3), 1315-1326 (2009).
84. Wang J, Rao S, Chu J et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 444(7117), 364-368 (2006). (Pubitemid 44764111)
85. Allegrucci C, Young LE. Differences between human embryonic stem cell lines. Hum. Reprod. Update 13(2), 103-120 (2007). (Pubitemid 46323190)
86. Loring JF, Rao MS. Establishing standards for the characterization of human embryonic stem cell lines. Stem Cells 24(1), 145-150 (2006).
87. Rosler ES, Fisk GJ, Ares X et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev. Dyn. 229(2), 259-274 (2004). (Pubitemid 38140465)
88. Maitra A, Arking DE, Shivapurkar N et al. Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 37(10), 1099-1103 (2005). (Pubitemid 41486662)
89. Baharvand H, Fathi A, van Hoof D, Salekdeh GH. Concise review: trends in stem cell proteomics. Stem Cells 25(8), 1888-1903 (2007). (Pubitemid 47258167)
90. Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19(3), 193-204 (2001). (Pubitemid 32524540)
91. Villen J, Gygi SP. The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry. Nat. Protoc. 3(10), 1630-1638 (2008).
92. Thingholm TE, Jensen ON, Larsen MR. Analytical strategies for phosphoproteomics. Proteomics 9(6), 1451-1468 (2009).
93. Blagoev B, Ong SE, Kratchmarova I, Mann M. Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat. Biotechnol. 22(9), 1139-1145 (2004). (Pubitemid 39166852)
94. Zhang Y, Wolf-Yadlin A, Ross PL et al. Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol. Cell Proteomics 4(9), 1240-1250 (2005). (Pubitemid 41448712)
95. Kruger M, Kratchmarova I, Blagoev B, Tseng YH, Kahn CR, Mann M. Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc. Natl Acad. Sci. USA 105(7), 2451-2456 (2008). (Pubitemid 351520534)
96. Olsen JV, Blagoev B, Gnad F et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127(3), 635-648 (2006). (Pubitemid 44647421)
97. Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308(5727), 1472-1477 (2005). (Pubitemid 40791302)
98. Swaney DL, Wenger CD, Thomson JA, Coon JJ. Human embryonic stem cell phosphoproteome revealed by electron transfer dissociation tandem mass spectrometry. Proc. Natl Acad. Sci. USA 106(4), 995-1000 (2009).
99. Brill LM, Xiong W, Lee KB et al. Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell 5(2), 204-213 (2009).
100. Van Hoof D, Munoz J, Braam SR et al. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 5(2), 214-226 (2009).
101. Hutchins AP, Robson P. Unraveling the human embryonic stem cell phosphoproteome. Cell Stem Cell 5(2), 126-128 (2009).
102. Jorgensen C, Linding R. Simplistic pathways or complex networks? Curr. Opin. Genet. Dev. 20(1), 15-22 (2010).
103. Linding R, Jensen LJ, Ostheimer GJ et al. Systematic discovery of in vivo phosphorylation networks. Cell 129(7), 1415-1426 (2007). (Pubitemid 46962092)
104. Bakal C, Linding R, Llense F et al. Phosphorylation networks regulating JNK activity in diverse genetic backgrounds. Science 322(5900), 453-456 (2008).
105. Meshorer E, Misteli T. Chromatin in pluripotent embryonic stem cells and differentiation. Nat. Rev. Mol. Cell Biol. 7(7), 540-546 (2006). (Pubitemid 44036459)
106. Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 9(6), 465-476 (2008). (Pubitemid 351693975)
107. Kouzarides T. Chromatin modifications and their function. Cell 128(4), 693-705 (2007). (Pubitemid 46273577)
108. Campos EI, Reinberg D. Histones: annotating chromatin. Annu. Rev. Genet. 43, 559-599 (2009).
109. Azuara V, Perry P, Sauer S et al. Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 8(5), 532-538 (2006).
110. Bernstein BE, Mikkelsen TS, Xie XH et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2), 315-326 (2006).
111. Pan GJ, Tian SL, Nie J et al. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 1(3), 299-312 (2007). (Pubitemid 47355329)
112. Gonzalez R, Jennings LL, Knuth M et al. Screening the mammalian extracellular proteome for regulators of embryonic human stem cell pluripotency. Proc. Natl Acad. Sci. USA 107(8), 3552-3557 (2010).
113. Saladi SV, de la Serna IL. ATP dependent chromatin remodeling enzymes in embryonic stem cells. Stem Cell Rev. 6(1), 62-73 (2010).
114. Fazzio TG, Huff JT, Panning B. An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity. Cell 134(1), 162-174 (2008). (Pubitemid 351905738)
115. Mikkelsen TS, Hanna J, Zhang XL et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454(7200), 49-55 (2008). (Pubitemid 351931978)
116. Brandt WF, Holt C. The determination of the primary structure of histone f3 from chicken erythrocytes by automatic edman degradation. Eur. J. Biochem. 46(2), 407-417 (1974).
117. Goldknopf IL, Busch H. Isopeptide linkage between nonhistone and histone-2a polypeptides of chromosomal conjugate-protein-A24. Proc. Natl Acad. Sci. USA 74(3), 864-868 (1977). (Pubitemid 8068703)
118. Hunt LT, Dayhoff MO. Amino-terminal sequence identity of ubiquitin and nonhistone component of nuclear protein A24. Biochem. Biophys. Res. Commun. 74(2), 650-655 (1977). (Pubitemid 8022254)
119. Collas P. The current state of chromatin immunoprecipitation. Mol. Biotechnol. 45(1), 87-100 (2010).
120. Zhao XD, Han X, Chew JL et al. Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 1(3), 286-298 (2007). (Pubitemid 47370914)
121. Fouse SD, Shen Y, Pellegrini M et al. Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3K4/K27 trimethylation. Cell Stem Cell 2(2), 160-169 (2008). (Pubitemid 351168712)
122. Lister R, Pelizzola M, Dowen RH et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271), 315-322 (2009).
123. Hawkins R, Hon GC, K. Lee L et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells Cell Stem Cell 6(5), 479-491 (2010).
124. Jung HR, Pasini D, Helin K, Jensen ON. Quantitative mass spectrometry of histones h3.2 and h3.3 in suz12-deficient mouse embryonic stem cells reveals distinct, dynamic post-translational modifications at Lys-27 and Lys-36. Mol. Cell Proteomics 9(5), 838-850 (2010).
125. Beck HC, Nielsen EC, Matthiesen R et al. Quantitative proteomic analysis of posttranslational modifications of human histones. Mol. Cell Proteomics 5(7), 1314-1325 (2006). (Pubitemid 44103401)
126. Macek B, Waanders LF, Olsen JV, Mann M. Top-down protein sequencing and MS3 on a hybrid linear quadrupole ion trap-orbitrap mass spectrometer. Mol. Cell Proteomics 5(5), 949-958 (2006). (Pubitemid 43792803)
127. Zubarev RA, Kelleher NL, McLafferty FW. Electron capture dissociation of multiply charged protein cations. A nonergodic process. J. Am. Chem. Soc. 120(13), 3265-3266 (1998).
128. Syka JEP, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl Acad. Sci. USA 101(26), 9528-9533 (2004). (Pubitemid 38869270)
129. Galasinski SC, Resing KA, Ahn NG. Protein mass analysis of histones. Methods 31(1), 3-11 (2003). (Pubitemid 36945165)
130. Medzihradszky KF, Zhang X, Chalkley RJ et al. Characterization of Tetrahymena histone H2B variants and posttranslational populations by electron capture dissociation (ECD) Fourier transform ion cyclotron mass spectrometry (FT-ICR MS). Mol. Cell Proteomics 3(9), 872-886 (2004). (Pubitemid 39369200)
131. Pesavento JJ, Bullock CR, Leduc RD, Mizzen CA, Kelleher NL. Combinatorial modification of human histone H4 quantitated by two-dimensional liquid chromatography coupled with top down mass spectrometry. J. Biol. Chem. 283(22), 14927-14937 (2008).
132. Phanstiel D, Brumbaugh J, Berggren WT et al. Mass spectrometry identifies and quantifies 74 unique histone H4 isoforms in differentiating human embryonic stem cells. Proc. Natl Acad. Sci. USA 105(11), 4093-4098 (2008). (Pubitemid 351754340)
133. Eliuk SM, Maltby D, Panning B, Burlingame AL. High resolution electron transfer dissociation studies of unfractionated intact histones from murine embryonic stem cells using on-line capillary LC separation. Mol. Cell Proteomics 9(5), 824-837 (2010).
134. Ho L, Ronan JL, Wu J et al. An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc. Natl Acad. Sci. USA 106(13), 5181-5186 (2009).
135. Mak AB, Ni Z, Hewel JA et al. A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency. Mol. Cell Proteomics 9(5), 811-823 (2010).
136. Cordwell SJ, Thingholm TE. Technologies for plasma membrane proteomics. Proteomics 10(4), 611-627 (2010).
137. Ahn SM, Goode RJA, Simpson RJ. Stem cell markers: insights from membrane proteomics? Proteomics 8(23-24), 4946-4957 (2008).
138. Durr E, Yu J, Krasinska KM et al. Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat. Biotechnol. 22(8), 985-992 (2004). (Pubitemid 39014475)
139. Watarai H, Hinohara A, Nagafune J, Nakayama T, Taniguchi M, Yamaguchi Y. Plasma membrane-focused proteomics: dramatic changes in surface expression during the maturation of human dendritic cells. Proteomics 5(15), 4001-4011 (2005). (Pubitemid 41502495)
140. Cao R, Li X, Liu Z et al. Integration of a two-phase partition method into proteomics research on rat liver plasma membrane proteins. J. Proteome Res. 5(3), 634-642 (2006). (Pubitemid 43364104)
141. McCarthy FM, Burgess SC, van den Berg BH, Koter MD, Pharr GT. Differential detergent fractionation for non-electrophoretic eukaryote cell proteomics. J. Proteome Res. 4(2), 316-324 (2005). (Pubitemid 40548135)
142. Chen R, Jiang X, Sun D et al. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J. Proteome Res. 8(2), 651-661 (2009).
143. Zhang H, Li XJ, Martin DB, Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 21(6), 660-666 (2003). (Pubitemid 36638093)
144. Zhao Y, Zhang W, Kho Y. Proteomic analysis of integral plasma membrane proteins. Anal. Chem. 76(7), 1817-1823 (2004). (Pubitemid 38451494)
145. Tan S, Tan HT, Chung MC. Membrane proteins and membrane proteomics. Proteomics 8(19), 3924-3932 (2008).
146. Nagano K, Yoshida Y, Isobe T. Cell surface biomarkers of embryonic stem cells. Proteomics 8(19), 4025-4035 (2008).
147. Nunomura K, Nagano K, Itagaki C et al. Cell surface labeling and mass spectrometry reveal diversity of cell surface markers and signaling molecules expressed in undifferentiated mouse embryonic stem cells. Mol. Cell Proteomics 4(12), 1968-1976 (2005). (Pubitemid 41830191)
148. Foster LJ, Zeemann PA, Li C, Mann M, Jensen ON, Kassem M. Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells 23(9), 1367-1377 (2005). (Pubitemid 41504924)
149. Harkness L, Christiansen H, Nehlin J, Barington T, Andersen JS, Kassem M. Identification of a membrane proteomic signature for human embryonic stem cells independent of culture conditions. Stem Cell Res. 1(3), 219-227 (2008).
150. Intoh A, Kurisaki A, Yamanaka Y et al. Proteomic analysis of membrane proteins expressed specifically in pluripotent murine embryonic stem cells. Proteomics 9(1), 126-137 (2009).
151. Van Hoof D, Dormeyer W, Braam SR et al. Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J. Proteome Res. 9(3), 1610-1618 (2010).
152. Stadtfeld M, Maherali N, Breault DT, Hochedlinger K. Defining molecular cornerstomes during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell. 2(3), 230-240 (2008).
153. Wobus AM, Boheler KR. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol. Rev. 85(2), 635-678 (2005). (Pubitemid 40404638)
154. Cowan CA, Klimanskaya I, McMahon J et al. Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350(13), 1353-1356 (2004). (Pubitemid 38375373)
155. Huttenhain R, Malmstrom J, Picotti P, Aebersold R. Perspectives of targeted mass spectrometry for protein biomarker verification. Curr. Opin. Chem. Biol. 13(5-6), 518-525 (2009).